IRAK4 inhibitors display synergistic activity when combined with BTK or PI3K inhibitors in B-cell lymphomas.

Drug Category : Array
Conference Category : Array
Lead Author : Vajda E, Marschke K, et al.
Published Date : 18/04/2015
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2019/03/IRAK%20AACR%20Poster.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top